FMR1 and fragile X-associated tremor/ataxia syndrome: Premutation repeat size has been found to be a critical factor on the molecular and clinical level in FXTAS, with a significant correlation between repeat size and age of symptom onset as well as reduced FMRP and increased FMR1 transcription (17, 45).